FST-201 In The Treatment of Acute Fungal Otitis Externa
Status: | Terminated |
---|---|
Conditions: | Infectious Disease |
Therapuetic Areas: | Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | July 2009 |
End Date: | July 2010 |
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
The objective of this study is to evaluate the efficacy of FST-201 compared to vehicle in
the treatment of acute fungal otitis externa. This trial is designed to enable filing of a
New Drug Application in support of FST-201 for the indication of acute fungal otitis
externa.
the treatment of acute fungal otitis externa. This trial is designed to enable filing of a
New Drug Application in support of FST-201 for the indication of acute fungal otitis
externa.
Inclusion Criteria:
- Have a clinical diagnosis of AFOE of in one or both ears, based on a clinical score
of at least 1 for edema (0-3 scale), 2 for overall inflammation (0-3 scale) and 1 for
tenderness (absent=0, present=1) and/or 1 for pruritis (absent = 0, present = 1)
- Have appearance consistent with fungal debris, i.e. white or black appearance
consistent with Aspergillus spp. or Candida spp.
- Be at least 18 years of age at Visit 1 (Day 1, Screening/Baseline) of either sex and
any race
- Provide written informed consent
- Be willing and able to follow all instructions and attend all study visits
- If female and of child bearing potential, agree to and submit a urine sample for
pregnancy testing at Visit 1 and upon their exit from the study. Post menopausal is
defined as having no menses for 12 consecutive months.
Exclusion Criteria:
- Have known sensitivity to any component of the study medications
- Have a current infection requiring systemic antimicrobial treatment
- Take any systemic (within 30 days) or otic corticosteroids (within 1 day) prior to
Visit 1
- Have used topical or systemic anti-inflammatory agents on the same day as Visit 1 and
for the duration of the study
- Have used topical or systemic pain medications on the same day as Visit 1 and for the
duration of the study
- Have used any topical otic treatment within 1 days prior to Visit 1
We found this trial at
5
sites
Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials
